Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.770
+0.070 (4.12%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Metagenomi Stock Forecast
MGX's stock price has decreased by -73.5% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Metagenomi stock have an average target of 13, with a low estimate of 6.00 and a high estimate of 20. The average target predicts an increase of 634.46% from the current stock price of 1.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Metagenomi stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
Buy | 3 | 3 | 3 | 3 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $7 | Strong Buy | Maintains | $14 → $7 | +295.48% | Apr 3, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +1,029.94% | Mar 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +690.96% | Dec 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +295.48% | Nov 21, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +747.46% | Nov 20, 2024 |
Financial Forecast
Revenue This Year
32.23M
from 52.30M
Decreased by -38.37%
Revenue Next Year
34.47M
from 32.23M
Increased by 6.95%
EPS This Year
-2.43
from -2.36
EPS Next Year
-2.29
from -2.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 48.9M | 71.4M | 17.6M |
Avg | 32.2M | 34.5M | 13.5M |
Low | 9.8M | 9.8M | 9.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -6.4% | 121.5% | -48.9% |
Avg | -38.4% | 7.0% | -60.8% |
Low | -81.3% | -69.6% | -71.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.54 | -0.57 | -2.99 |
Avg | -2.43 | -2.29 | -3.31 |
Low | -3.52 | -3.53 | -3.63 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.